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Introduction
Hepatitis B virus (HBV) is a major public health problem worldwide. Blood transfusion is one of the most common routes for spread of infection. In order to reduce the transmission of HBV, pretransfusion screening of blood donors by serum HBsAg was being carried out. However it was observed that HBV transmission can still occur from HBsAg negative blood donors despite above screening measures. Thus, the term occult Hence, there is a requirement for evaluation of Occult HBV infection (OBI). HBV DNA screening, therefore, carries lot of significance in certain clinical contexts. As HBV DNA is expensive and laboratory intensive; anti-HBc total, as a marker of previous HBV infection, in this situation, becomes an appropriate screening tool.
Material and methods
The study was done at a tertiary care center from June 2012 till Dec 2013. At least 50 patients in each subset with negative HBsAg test (by standard kits) were included. The inclusion subsets of patients were (i) blood donors, (ii) alcohol dependence syndrome (ADS) fulfilling CAGE criteria, (iii) alcoholics with cirrhosis of liver, (iv) patients of HCV or cryptogenic cirrhosis (diagnosis of cirrhosis of liver was considered on the basis of history, clinical signs and symptoms, USG abdomen for liver echotexture, portal vein size, ascites, and or UGI endoscopy for esophageal varices), (v) patients of malignancy prior to chemotherapy, (vi) end-stage renal disease (ESRD) patients on at least one year of haemodialysis (diagnosis of ESRD was considered on the basis of uremic symptoms), GFR <15, which was calculated as creatinine clearance by Cockcroft gault formula and deranged RFT for 3 months or more duration, (vii) HIV positive individuals. The following patient groups were excluded; (i) HBsAg positive individuals in above categories, (ii) age <18 and >75 year, (iii) pregnancy, (iv) patients having overlap between two categories.
All patients were subjected to detailed history, complete physical examination, hematological and biochemical investigations as per protocol, an ultrasonography abdomen for features of cirrhosis was done in all patients for fulfilling inclusion and exclusion criteria; HBsAg and anti-HCV, HIV TEST was done by ELISA in all patients, anti-HBc total was measured in all the patients. HBV DNA analysis was done by real time PCR in patients, who were found positive for anti-HBc total.
Results
This study included 369 patients of various categories. The mean age of the patients was ranging from 32 to 58 years (Table 1) . A majority of males were noted in the study population more so in the subsets of ADS patients and alcoholic cirrhotics (Table 2 ). There were 55 blood donors, 59 ADS patients, 51 patients of alcoholic cirrhosis, 50 patients of HCV/cryptogenic cirrhosis and 52 patients of ESRD on maintenance haemodialysis, 50 patients of malignancy before starting chemotherapy and 52 HIV positive patients. A total of 60/369 (16.2%) individuals were found to be anti-HBc total positive, who were negative for HBsAg (Table 3) . Maximum prevalence of anti-HBc total was found in HCV or cryptogenic cirrhosis group 13/50 (26%), followed by HIV positive patients 
